S08.2: Does reimbursement of a smoking cessation program pay off? An economic analysis from the perspective of a private health insurance fund

2004 ◽  
Vol 46 (S1) ◽  
pp. 17-17
Author(s):  
Ernst-Günther Hagenmeyer ◽  
Holger Gothe ◽  
Ursula Berger ◽  
Robert Hartog ◽  
Bertram Häussler
Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Iris Tinsel ◽  
Gloria Metzner ◽  
Christian Schlett ◽  
Matthias Sehlbrede ◽  
Martina Bischoff ◽  
...  

Abstract Background A healthy lifestyle can help prevent diseases that impair quality of life and lead to premature death. The Techniker health insurance fund offers a comprehensive online health program to support users in achieving their health goals of Increasing Fitness, Losing and Maintaining Weight, or Smoking Cessation. Methods The aim of this study is to test the long-term effectiveness of the web-based TK-HealthCoach with regard to the primary outcomes of increased physical activity, sustainable weight reduction, and smoking abstinence. We are conducting three interconnected, randomized controlled trials (RCT), one for each health goal, within which participants are allocated to an intervention group (interactive online health program) or a control group (non-interactive online health program). The effects of the intervention groups compared to the control groups will be analyzed by multi-level models for change. Participants’ data are captured via online questionnaires before the program starts (baseline t0), again when it ends (t1), and later at two follow-up surveys (t2 and t3); the latter 12 months after t1. We are documenting socio-demographic, health-related, and psychological variables as well as usage behavior data of the programs. According to our sample size calculation, we have to enroll 1114 participants in each Losing and Maintaining Weight and Increasing Fitness RCT and 339 participants in the Smoking Cessation RCT. Additionally, 15–20 participants in the interactive smoking-cessation program will be invited to qualitative telephone interviews with the aim to obtain detailed information concerning utilization, compliance, and satisfaction. The online RCTs’ inclusion criteria are: adults of each gender regardless of whether they are insured with Techniker health insurance fund. Persons with impairments or pre-existing conditions require a medical assessment as to whether the program is suitable for them. Specific exclusion criteria apply to each program/RCT. Discussion We assume that study participants will improve their health behavior by using the offered online health programs and that each health goal’s intervention group will reveal advantages regarding the outcome variables compared to the control groups. Study enrollment started on January 1, 2020. Trial registration German Clinical Trials Register, Universal Trial Number (UTN): U1111-1245-0273. Registered on 11 December 2019


2014 ◽  
Vol 155 (17) ◽  
pp. 669-675
Author(s):  
Gábor Simonyi

Introduction: Dyslipidemia is a well-known cardiovascular risk factor. To achieve lipid targets patient adherence is a particularly important issue. Aim: To assess adherence and persistence to statin therapy in patients with atherosclerotic disease who participated in the MULTI Goal Attainment Problem 2013 (MULTI GAP 2013) study. Patient adherence was assessed using estimation by the physicians in charge and analysis of pick up rate of prescribed statins in 319 patients based on data of National Health Insurance Fund Administration of Hungary. Method: In the MULTI GAP 2013 study, data from standard and structured questionnaires of 1519 patients were processed. Serum lipid values of patients treated by different healthcare professionals (general practitioners, cardiologists, diabetologists, neurologists, and internists), treatment adherence of patients assessed by doctors and treatment adherence based on data of National Health Insurance Fund Administration of Hungary were analysed. Satisfaction of doctors with results of statin therapy and the relationship between the level of adherence and serum lipid values were also evaluated. Results: Considering the last seven years of survey data, the use of more effective statins became more prevalent with an about 70% increase of prescriptions of atorvastatin and rosuvastatin from 49% to 83%. Patients with LDL-cholesterol level below 2.5 mmol/l had 8 prescriptions per year. In contrast, patients who had LDL-cholesterol levels above 2.5 mmol/l had only 5.3–6.3 prescriptions per year. Patients who picked up their statins 10–12 or 7–9 times per year had significantly lower LDL-cholesterol level than those who had no or 1–3 pick up. The 100% persistence assessed by doctors was significantly lower (74%) based on data from the National Health Insurance Fund Administration of Hungary. About half of the patients were considered to display 100% adherence to lipid-lowering therapy by their doctors, while data from the National Health Insurance Fund Administration of Hungary showed only 36%. In patients with better adherence (90–100%) LDL-cholesterol levels below 2.5 mmol/l were more frequent (59.5%) compared to those with worse adherence. Satisfaction of doctors with lipid targets achieved was 69–80% in patients with total cholesterol between 4.5 and 6 mmol/l, and satisfaction with higher cholesterol values was also high (53–54%). Conclusions: The results show that doctors may overestimate patient adherence to lipid-lowering treatment. Based on data from the National Health Insurance Fund Administration of Hungary, satisfaction of doctors with high lipid level appears to be high. There is a need to optimize not only patient adherence, but adherence of doctors to lipid guidelines too.


2020 ◽  
Vol 25 (03) ◽  
pp. 128-129

Weinhold et al. Economic impact of disease prevention in a morbidity-based financing system: does prevention pay off for a statutory health insurance fund in Germany? Eur J Health Econ 2019; 20 (8): 1181–1193 Das deutsche Gesundheitssystem wird durch vermeidbare chronische Erkrankungen in besonderem Maße belastet. Die Finanzierung geeigneter Präventionsmaßnahmen obliegt den Krankenkassen. Weinhold et al. untersuchten in einer retrospektiven Studie die ökonomischen Auswirkungen von Prävention für die GKV.


2009 ◽  
Vol 42 (02) ◽  
pp. 66-71 ◽  
Author(s):  
S. Weinbrenner ◽  
H.-J. Assion ◽  
T. Stargardt ◽  
R. Busse ◽  
G. Juckel ◽  
...  

1913 ◽  
Vol 13 (2) ◽  
pp. 91-110

The Kazan Society of Physicians for the Provision of Medical Aid to the Participants of the Health Insurance Funds Established on the Basis of the Law of June 23, 1912 "has the goal of providing medical assistance to the participants of the Health Insurance Fund established on the basis of the Law of June 23, 1912 in the city of Kazan and its environs.


2012 ◽  
Vol 153 (9) ◽  
pp. 344-350 ◽  
Author(s):  
Miklós Gresz ◽  
Júlia Nagy ◽  
Petra Freyler

In recent times, the topic of smoking has been extensively debated in Hungary. A new Act has been issued for the protection of non-smokers and for the regulation of tobacco product distribution. Aims: The aim of the authors was to examine the economic burden of smoking on the society. Methods: According to wildly accepted estimates, 30% of the Hungarian population smokes. Smoking leads to the development of several diseases, for example, it is responsible for 90% of lung cancer cases. Results: 17.2% of the curative–preventive costs and 15% of the pharmaceutic costs are estimated to be spent on the health damages caused by smoking. In 2009, the Health Insurance Fund had to spend approximately 174.6 billion HUF for health damages including sick leave costs caused by smoking. Working days lost (patients on sick list) as a consequence of smoking decreased the GDP of Hungary by around 95 billion HUF in the same year. Literature suggests that smoking leads to a loss of approximately seven life years. Shortened life span might cause 594.9 billion HUF loss to the Hungarian economy not to mention the economical and emotional loss of the individual families. Conclusions: The authors estimated a total of 864.4 billion HUF loss to the Hungarian economy due to smoking. Orv. Hetil., 2012, 153, 344–350.


2018 ◽  
Vol 21 ◽  
pp. S104
Author(s):  
D Endrei ◽  
A Sebestyén ◽  
I Ágoston ◽  
T Csákvári ◽  
G Kovács ◽  
...  

Author(s):  
Elena Frolova

Belgium is a small country in northwestern Europe, with a population of 11.4 million people. The country has a very high level of urbanization; up to 97% of the population lives in cities and towns. About 10% of GDP is spent annually on the development of healthcare, which, technically, corresponds to the average European indicators. Based on the results of work in 2018, the Belgian medical care delivery system was recognized as the “most generous healthcare system in Europe”, however, it was rated much lower in terms of quality than the countries that took first places in the ranking. The country has a public and private healthcare system, and both of them are paid. 99% of the population is covered by medical insurance, and children under the age of 18 are covered by parental insurance. All officially employed Belgians and self-employed persons operating in the country must be registered and make contributions to the Belgian Health Insurance Fund. The amount of the monthly contribution to the Health Insurance Fund is fixed, it amounts to 7.35% of the salary.


Sign in / Sign up

Export Citation Format

Share Document